YOUR BUSINESS AUTHORITY
Springfield, MO
Johnson & Johnson penned a $14.6 billion deal to buy neurological drugmaker Intra-Cellular Therapies.
The deal is expected to boost J&J's footprint in the brain disease treatment market.
The deal is J&J's largest in at least two years.
Read more from Reuters.
Project work in Springfield corridor will continue into 2031.